3B64.12ICD-11 MMS 2026-01
Drug-induced thrombocytopenic purpura
Description
Thrombocytopenic purpura attributable to drug toxicity (e.g. cytotoxic chemotherapeutic or immunosuppressive agents) or to an idiosyncratic drug-associated allergic thrombocytopenia (e.g. quinine, thiazides).
Index terms
- Drug-induced thrombocytopenic purpura
- Drug-induced immune thrombocytopenia
- medicament-induced immune thrombocytopenia
Show allHide
- Drug-induced non-immune thrombocytopenia
- Heparin-induced thrombocytopenia
- Heparin-induced thrombosis/thrombocytopenia syndrome
- Heparin skin necrosis due to immune heparin-induced thrombocytopenia
- HITTS - [Heparin-induced thrombocytopenia and thrombosis syndrome]
- Heparin-induced thrombocytopenia, Type 1
- Heparin-induced thrombocytopenia, Type 2
- Drug-induced thrombocytopenic purpura specified as refractory
Exclusions from above levels
JA43.3– Postpartum coagulation defects04– Diseases of the immune system05– Endocrine, nutritional or metabolic diseases
Show allHide
18– Complications of pregnancy, childbirth or the puerperium19– Certain conditions originating in the perinatal period20– Congenital malformations, deformations or chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes- http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1– Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium
Sibling codes
Foundation entity
Drug-induced thrombocytopenic purpura – http://id.who.int/icd/entity/7135461
Allowed postcoordination axes
Part of: 3B64.1: Acquired thrombocytopenia › 3B64: Thrombocytopenia › 03: Diseases of the blood or blood-forming organs